- Home
- ECOR vs THTX Comparison
ECOR vs THTX Comparison
Compare ECOR & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- THTX
- Stock Information
- Founded
- ECOR 2005
- THTX 1993
- Country
- ECOR United States
- THTX Canada
- Employees
- ECOR N/A
- THTX N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- ECOR Health Care
- THTX Health Care
- Exchange
- ECOR Nasdaq
- THTX Nasdaq
- Market Cap
- ECOR 111.3M
- THTX 93.3M
- IPO Year
- ECOR 2018
- THTX N/A
- Fundamental
- Price
- ECOR $15.90
- THTX $1.72
- Analyst Decision
- ECOR Strong Buy
- THTX Hold
- Analyst Count
- ECOR 1
- THTX 1
- Target Price
- ECOR $25.00
- THTX N/A
- AVG Volume (30 Days)
- ECOR 144.8K
- THTX 178.5K
- Earning Date
- ECOR 03-12-2025
- THTX 02-19-2025
- Dividend Yield
- ECOR N/A
- THTX N/A
- EPS Growth
- ECOR N/A
- THTX N/A
- EPS
- ECOR N/A
- THTX N/A
- Revenue
- ECOR $23,327,000.00
- THTX $84,316,000.00
- Revenue This Year
- ECOR $59.81
- THTX $5.78
- Revenue Next Year
- ECOR $38.49
- THTX $2.47
- P/E Ratio
- ECOR N/A
- THTX N/A
- Revenue Growth
- ECOR 74.10
- THTX 5.75
- 52 Week Low
- ECOR $5.32
- THTX $1.08
- 52 Week High
- ECOR $18.67
- THTX $2.18
- Technical
- Relative Strength Index (RSI)
- ECOR 53.73
- THTX 50.28
- Support Level
- ECOR $15.50
- THTX $1.69
- Resistance Level
- ECOR $16.12
- THTX $1.83
- Average True Range (ATR)
- ECOR 1.20
- THTX 0.13
- MACD
- ECOR -0.31
- THTX -0.04
- Stochastic Oscillator
- ECOR 40.17
- THTX 19.30
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.